Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings.
Affected assets and topics
Why it matters
Abbott Laboratories' stock is experiencing its worst day since 2000 due to underwhelming fourth-quarter earnings and sales, despite beating analyst expectations for adjusted earnings.
Expected market reaction
Market impact analysis based on bearish sentiment with 90% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 36092
Original source
Shares of Abbott Laboratories sank on Thursday after the medical device maker posted fourth-quarter earnings and sales that underwhelmed Wall Street. For the fourth quarter, Abbott reported adjusted earnings of $1.50 a share, slightly better than the $1.49 consensus among analysts tracked by FactSet The company logged roughly $11.5 billion in sales, missing the $11.8 billion analysts had forecast. The company said it expects full-year adjusted earnings in the range of $5.55 to $5.80 a share.
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on January 22, 2026. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
Llama 3.1 8B Instant (Groq) · 40.5% correct across 1187 scored calls on indices See the full record